JPMC Drugs and Pharmaceuticals

The State of Illinois is procuring a Joint Purchase Master Contract (JPMC) for the provision of drugs and pharmaceuticals through an Invitation for Bid (IFB) process. The contract will be awarded to a professional, qualified, and licensed pharmaceutical wholesaler to provide brand name and generic drugs and pharmaceuticals for state agencies, local governments, and qualified not-for-profit organizations. The procurement covers a wide range of pharmaceutical products spanning multiple therapeutic categories, with detailed line-item quantities and descriptions provided in the historical usage data. The contract term is up to 10 years with no renewal options. Bidders must submit their bids electronically through the State's BidBuy procurement system and include completed forms, price lists, and a Minorities, Women, and Persons with Disabilities Participation and Utilization Plan. Pricing must be submitted as a percent discount off the Wholesale Acquisition Cost (WAC) and Public Health Services (PHS) pricing, with the discount percentage remaining stable throughout the contract. The contract will be awarded to the responsive and responsible bidder who submits the lowest overall price, with the State reserving the right to award by line item.

The solicitation includes a 9% Business Enterprise Program (BEP) participation goal, and bidders must demonstrate their good faith efforts to meet this requirement. While the contract is open to all qualified vendors, the State has listed three potential BEP-certified vendors in an addendum to the solicitation. There is no small business set-aside or veteran small business participation goal for this contract. The estimated annual value of the contract is $100 million, and the State has provided historical usage data from October 2018 through September 2021 to assist bidders in preparing their responses.